2-(pyridin-2-ylamino)-pyrido[2,3-D]pyrimidin-7-ones
USRE47739E1 · kind E1 · reissue
7Cited by
23References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 2018 |
| Grant date | Nov 26, 2019 |
| Priority date | — |
| Expiry date | Jul 27, 2038 |
Classification
- Technology area (CPC —)General
Abstract
The present invention provides substituted 2-aminopyridines useful in treating cell proliferative disorders. The novel compounds of the present invention are potent inhibitors of cyclin-dependent kinases 4 (cdk4)
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.